Compare MKS Instruments (MKSI) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MKS Instruments vs Relay Therapeutics Inc. Common Stock — how do they compare? MKS Instruments trades at $262.78 (market cap $17.61B), while Relay Therapeutics Inc. Common Stock trades at $18.24 (market cap $3.82B). The key difference: MKS Instruments is far larger — about 4.6× Relay Therapeutics Inc. Common Stock's market cap, and MKS Instruments pays a 0.38% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold MKS Instruments for 7 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| MKSI | RLAY | |
|---|---|---|
Market Cap | $17.61B | $3.82B |
Volume | 1,275,355 | 4,332,079 |
Sector | Technology | Health |
52-Week High | $444.80 | $20.75 |
52-Week Low | $121.26 | $6.03 |
Typical Hold Time | 7 Days | 0 Days |
Enterprise Value | $21.18B | $2.93B |
Dividend Yield | 0.38% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About MKS Instruments
MKS develops instruments, systems, and process control solutions for advanced manufacturing. Its technologies serve semiconductor manufacturing, electronics and packaging, photonics, and specialty industrial applications.
Read more on MKSI →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
